Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

Company Overview

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Key Stats

• Today's Range: $0.43 to $0.43
• 50-Day Range: $0.40 to $0.61
• 52-Week Range: $0.31 to $0.89
• Volume: 429 shs
• Average Volume: 11,719 shs
• Market Capitalization: $9.86 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Pharma-Bio Serv Stock Analysis - MarketRank™

Pharma-Bio Serv scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Pharma-Bio Serv.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Pharma-Bio Serv is -14.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Pharma-Bio Serv is -14.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Pharma-Bio Serv has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Pharma-Bio Serv has been sold short.

Short Interest Ratio / Days to Cover

Pharma-Bio Serv has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

Pharma-Bio Serv does not currently pay a dividend.

Dividend Growth

Pharma-Bio Serv does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the float of Pharma-Bio Serv has been sold short.

Short Interest Ratio / Days to Cover

Pharma-Bio Serv has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

Pharma-Bio Serv has a news sentiment score of -0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Business Services companies.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Pharma-Bio Serv insiders have not sold or bought any company stock.

Percentage Held by Insiders

12.20% of the stock of Pharma-Bio Serv is held by insiders. A high percentage of insider ownership can be a sign of company health.

PBSV Stock Analysis - Frequently Asked Questions

How have PBSV shares performed this year?

Pharma-Bio Serv's stock was trading at $0.5499 on January 1st, 2025. Since then, PBSV shares have decreased by 21.8% and is now trading at $0.43.
View the best growth stocks for 2025 here.

How were Pharma-Bio Serv's earnings last quarter?

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) issued its earnings results on Monday, March, 17th. The company reported $0.37 earnings per share for the quarter, beating analysts' consensus estimates of $0.02 by $0.35. The firm earned $2.47 million during the quarter, compared to analyst estimates of $2.70 million. Pharma-Bio Serv had a negative trailing twelve-month return on equity of 5.61% and a negative net margin of 8.18%.

How do I buy shares of Pharma-Bio Serv?

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Pharma-Bio Serv own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), General Electric (GE), Exxon Mobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP).

Company Calendar

• Record date for 3/20 Dividend: 2/28/2025
• Ex-Dividend for 3/20 Dividend: 2/28/2025
• Last Earnings: 3/17/2025
• Dividend Payable: 3/20/2025
• Today: 3/29/2025
• Next Earnings (Estimated): 6/13/2025
• Fiscal Year End: 10/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Business Services
• Industry: Management consulting services
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:PBSV
• CIK: 1304161
• Web: www.pharmabioserv.com
• Phone: (787) 278-2709
• Fax: 787-796-5168
• Employees: 185
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 3.91
• P/E Growth: N/A
• Net Income: $-780,000.00
• Net Margins: -8.18%
• Pretax Margin: -7.94%
• Return on Equity: -5.61%
• Return on Assets: -4.53%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.32
• Quick Ratio: 8.32

Sales & Book Value

• Annual Sales: $9.51 million
• Price / Sales: 1.04
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.60 per share
• Price / Book: 0.72

Miscellaneous

• Outstanding Shares: 22,932,000
• Free Float: 20,162,000
• Market Cap: $9.86 million
• Optionable: Not Optionable
• Beta: 0.53